XtendFlex soybean technology has been approved by the European Commission for food, feed, import and processing use in the European Union, Bayer announced Monday, Sept. 28. Other major export partners, including China, already had approved the product, according to published reports.
"This milestone represents the final key authorization for XtendFlex soybeans. With this approval in hand, Bayer can now look forward to a full launch in the United States and Canada in 2021 and expects to be in a strong position to supply 20 million U.S. soy acres when the selling season arrives," Bayer said in a written statement.
According to Bayer:
Products with Xtend Technology contain genes that confer tolerance to glyphosate, glufosinate and dicamba. XtendFlex soybeans are built on Roundup Ready 2 Xtend soybean technology and provide farmers with more flexibility in managing tough-to-control and resistant weeds.
“We’ve seen great demand for XtendFlex soybeans from our customers,” said Lisa Streck, Bayer soybean launch lead. “Based on that demand, we’ve developed a supply plan to meet the market demand in 2021, across all maturities, Bayer brands and licensees. We expect the launch of XtendFlex to match the launch scale of Roundup Ready 2 Xtend soybeans, which were planted on 20 million acres in their first year of commercial availability."
ADVERTISEMENT
Bayer describes itself as "a a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. "
